Form 4: Dorman Products VP Exercises, Sells Shares
Insider Transaction Report
Dorman Products' VP, Chief Accounting Officer, Gregory C. Bowen, exercised stock options and subsequently sold an equal number of common shares under a Rule 10b5-1 plan.
Summary
- Gregory C. Bowen, VP, Chief Accounting Officer, exercised 1,453 employee stock options for Dorman Products, Inc. common stock on September 12, 2025, at an exercise price of $101.45 per share.
- Concurrently, Mr. Bowen sold 1,453 shares of Dorman Products, Inc. common stock on September 12, 2025, at a price of $162.808 per share.
- These transactions were conducted under a Rule 10b5-1 pre-arranged trading plan.
- Following these transactions, Mr. Bowen directly beneficially owns 4,658.9296 shares of common stock and 0 derivative securities.
Sentiment
Score: 6
Explanation: The transaction is a routine insider sale under a 10b5-1 plan, indicating personal financial management rather than a strong signal about the company's future. The profitable exercise and sale are positive for the insider, but the reduction in direct ownership could be seen as slightly negative by some investors, though mitigated by the pre-planned nature.
Positives
- The sale price of $162.808 per share is significantly higher than the exercise price of $101.45, indicating a profitable transaction for the insider.
- The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-planned sale not based on immediate, non-public information.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake in the company.
Stakeholder Impact
- Shareholders: May observe a slight reduction in insider ownership, though the Rule 10b5-1 plan mitigates concerns about market timing.
Key Dates
| Date | Description |
|---|---|
| 03/02/2021 | Approximate grant date of the employee stock option (vesting began on the first anniversary, March 2, 2022). |
| 03/02/2022 | First anniversary of the option grant date, when the first of four equal annual installments of the option vested. |
| 09/12/2025 | Date of common stock acquisition (option exercise) and disposition (sale). |
| 09/15/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
| 03/02/2029 | Expiration date of the employee stock option. |
Recommendation
holdThis Form 4 filing details a routine insider transaction (exercise of options and subsequent sale of shares) executed under a Rule 10b5-1 plan. Such transactions are typically pre-scheduled for personal financial management and do not usually signal a change in the company's fundamental outlook or performance. While the insider profited from the transaction, the reduction in direct ownership is minor and expected under such plans. Therefore, it does not provide a strong basis for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate as investors should rely on broader company fundamentals and market conditions rather than this specific insider filing.
Keywords
Dorman Products, DORM, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Gregory C. Bowen, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.